We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Casirivimab/imdevimab

Australian Public Assessment Report

AusPAR

AusPAR: Casirivimab/imdevimab [PDF, 2.49 MB]

AusPAR: Casirivimab/imdevimab [Word, 15.34 MB]

Attachment: Product Information for Casirivimab/imdevimab [PDF, 597.17 KB]

Attachment: Product Information for Casirivimab/imdevimab [Word, 453.25 KB]

Device/Product Name

Ronapreve

Active ingredients

Casirivimab/imdevimab

AusPAR Date

25 October 2021

Published

2 November 2021

Submission Number

PM-2021-03952-1-2

Submission Type

New biological entity

Decision

Approved for provisional registration